Using mass photometry to explore the evolution of carbon fixation
Form I Rubisco is one of the most abundant enzymes on Earth. It is responsible for assimilating atmospheric CO2 into organic matter, but how it obtained its high CO2 specificity is unknown.
Refeyn Expands into AAV-based Gene Therapy Manufacturing with GMP Software
The new SamuxMP software package for GMP empowers AAV manufacturing facilities with advanced process optimization capabilities
Using mass photometry to study compact CRISPR-Cas12f1 complexes
Due to its precise genome editing capabilities, the prokaryotic CRISPR–Cas system has revolutionized molecular biology – and has potential applications in gene therapy and biotechnology [1]. Nonetheless, recent research has highlighted the need for more compact CRISPR-Cas complexes, which could be delivered to cellular systems more efficiently [2]
Happy 500 (papers) to mass photometry!
There is no better measure for the success of an analytical technology than its widespread adoption by the people who need the best data! As news of the capabilities and applications of mass photometry spreads, more and more scientists are choosing to use it. In fact, the number of scientific publications relying on mass photometry has grown by an average of 168% per year over the past 6 years. In August 2024, we hit a new milestone: 500 mass photometry papers! For a technology as young as mass photometry, that is truly remarkable.
MassFluidix HC upgrade enhances high-concentration analysis
Refeyn has taken another step to assure mass photometry is a simpler, more efficient bioanalytics tool with the release of a powerful expansion of its consumables portfolio.
Refeyn forms new mass photometry Scientific Advisory Board
Refeyn has established a new Scientific Advisory Board, chaired by Justin Benesch, Professor of Biophysical Chemistry, Oxford University and co-founder of Refeyn. To recognize and help realize the full potential of mass photometry’s unique bioanalytical workflow capabilities, the new board includes external scientific experts in pharmaceutical and biologics discovery, process development and manufacture.
Speeding up gene therapy analytics
Genetic Engineering & Biotechnology News (GEN) published a short article discussing how researchers at the UK Centre for Process Innovation (CPI) found mass photometry to be a helpful analytical technique for companies using adeno-associated viruses (AAV) as viral vectors in gene therapies.
Macro mass photometry for rapid viral vector characterization
An article authored by Laura Pala, one of our Product Marketing Managers, has recently been published by Eurolab magazine and also online at ScientistLive. It provides a useful overview of macro mass photometry and how it can help to speed up viral vector characterization, a key analytical step within the production pipeline for cell and gene therapies (CGT) and vaccines.
New US headquarters opened in Waltham, Massachusetts
Refeyn staff join mass photometry inventor Prof. Philip Kukura in cutting ribbon to Refeyn’s new US customer interaction center in Massachusetts’ Waltham Biotech Hub
User innovation takes center stage at 2024 Mass Photometry Summit
The remarkable evolution of mass photometry was celebrated at the annual mass photometry user summit. From prototype to commercially available instrument used in hundreds of laboratories, this innovative technology was on display at the third annual scientific meeting of this event – dedicated to mass photometry users and hosted by Refeyn. The event took place at Wylie Conference Center on May 22 in Beverly, Massachusetts, a coastal suburb of Boston, USA.
